MedTrace Logo

Prospective Observational Cohort HIV & STI Study in Europe

NCT03866759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3593

Last updated 2022-11-29

No results posted yet for this study

Summary

The University Hospital Essen is sponsoring the Multicenter human immunodeficiency virus (HIV) and sexually transmitted infections Prevention Network Study (STIPnet) which is funded by Janssen, Pharmaceutical Companies of Johnson \& Johnson.

STIPnet study is a prospective observational cohort study aiming to determine the incidence and point prevalence of HIV infection and the most common sexually transmitted infections (STIs) in individuals with sexual risk behavior. In addition, the University Hospital Essen will examine whether individuals at risk for HIV and STI infections would retain in such a study (retention rate) and would be willing to participate in potential HIV and STI prevention trials (willingness to participate).

Conditions

Interventions

BEHAVIORAL

Determine the Incidence and Point Prevalence

Determine the Incidence and Point Prevalence of human immunodeficiency virus (HIV) Infection and the Most Common Sexually Transmitted Infections in Individuals With Sexual Risk Behavior.

Sponsors & Collaborators

  • Janssen, LP

    collaborator INDUSTRY

  • Hendrik Streeck

    lead OTHER

Principal Investigators

  • Hendrik Streeck, Prof. Dr. · Institute for HIV Research

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-24
Primary Completion
2022-08-22
Completion
2022-08-22

Countries

  • France
  • Hungary
  • Italy
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866759 on ClinicalTrials.gov